ENDRA Life Sciences Inc. Warrants
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ENDRA Life Sciences Inc. Warrants generated cash of -$11,122,384, which is less than the previous year. Cash used in financing activities reached the amount of $13,401,602 last year. Net change in cash is therefore $2,234,218.
Cash Flow
| 2014 | -1.39M | -275.37K | 1.75M |
|---|---|---|---|
| 2015 | -842.72K | -133.81K | 839.22K |
| 2016 | -1.31M | 0 | 1.44M |
| 2017 | -3.30M | -7.86K | 8.76M |
| 2018 | -7.70M | -100K | 8.67M |
| 2019 | -8.58M | -43.59K | 8.33M |
| 2020 | -10.74M | -75.33K | 11.87M |
| 2021 | -11.12M | -45K | 13.40M |
NDRAW Cash Flow Statement (2014 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.22M | 6.17M | 6.17M | 6.47M | 5.60M | 19.12K | 156.44K | 78.02K |
Operating activities | ||||||||
Net income | -11.35M | -11.72M | -17.52M | -9.79M | -5.37M | -2.77M | -2.27M | -2.18M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 224.41K | 99.34K | 2.47M | 797.55K | 772.95K | 64.93K | 72.22K | 37.24K |
Stock-based compensation expense | 1.44M | 0 | 0 | 0 | 0 | 230.32K | 309.83K | 259.49K |
| Deferred income tax benefit | 1.44M | 0 | 0 | 0 | 0 | 230.32K | 309.83K | 259.49K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | -7.43M | -4.57M | 6.85K | -6.85K | 0 | 0 | 0 |
Inventories | -694.95K | -476.17K | -53.99K | -155.30K | -151.57K | 58.89K | 139.98K | -60.21K |
Accounts payable | 491.10K | -834.99K | 760.14K | 126.36K | 528.29K | 0 | 0 | 0 |
Cash generated by operating activities | -11.12M | -10.74M | -8.58M | -7.70M | -3.30M | -1.31M | -842.72K | -1.39M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -45K | -75.33K | -43.59K | -100K | 0 | 0 | -133.81K | -275.37K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -45K | -75.33K | -43.59K | -100K | -7.86K | 0 | -133.81K | -275.37K |
Financing activities | ||||||||
Common Stock Issued | 1.44M | 2.10M | 125K | 7.73M | 8.59M | 5K | 839.22K | 1.75M |
Payments for dividends | -121.07K | -395.55K | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 13.40M | 11.87M | 8.33M | 8.67M | 8.76M | 1.44M | 839.22K | 1.75M |
Net Change In Cash | 2.23M | 1.05M | 0 | 0 | 0 | 125.82K | -137.31K | 78.41K |
Cash at end of period | 9.46M | 7.22M | 6.17M | 6.47M | 5.60M | 144.95K | 19.12K | 156.44K |
| Data source | Data source | Data source | Data source | Data source |